MedTrace Logo

Reversibility of Minimal Hepatic Encephalopathy Following Liver Transplantation

NCT02767622 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-05-11

No results posted yet for this study

Summary

This study included 20 patients listed for liver transplantation in addition to 20 age- and sex- matched controls. Neurological, psychiatric, laboratory and radiological examinations were performed for both patients and controls before and 6 months after liver transplantation. Assessment of cognitive functions by Trail Making Test A (TMT A), TMT B, Digit Symbol Test (DST), and Serial Dotting Test (SDT) was done before and after liver transplantation.

Conditions

  • Minimal Hepatic Encephalopathy

Interventions

PROCEDURE

Liver transplantation

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02767622 on ClinicalTrials.gov